Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: Netherlands Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20041
20065
20072
20092
20111
20121
20131
20142
20151
20162
20172
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
AbbVie3
Bristol-Myers Squibb3
Celgene3
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Maastricht Radiation Oncology2
Dr. B. Biesma1
ETOP IBCSG Partners Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma29
Lung Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Neoplasm Metastasis3
Neoplasms2
Ovarian Neoplasms2
Recurrence2
Breast Neoplasms, Male1
Carcinoma1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.